Frontier Markets: Banking on Further Kuwaiti Catalysts

Upon returning from our November 2017 research visit to Kuwait, we felt confident the economy was on improved footing after what had been an extended hangover from the 2008 financial crisis. However, what stopped us from getting more excited at the time was the fact many stocks had rallied hard on FTSE Russell’s announcement to move Kuwait to its Emerging Markets Index. Despite some positive meetings and witnessing companies making decent fundamental improvements, valuations appeared rich and we felt comfortable maintaining our significant country-level underweight.

BMO Global Asset Management focuses on trust

Asset management is all about trust as emerging market (EM) specialists at LGM, part of BMO Global Asset Management, explain in this video. They go on to describe the fundamentals for the EM investment case, and why they are so strong. As lead portfolio manager, Rishikesh Patel said: “Some 75% of the world’s population are […]

BB Biotech: Investing in medical research which changes lives

Analyst and Portfolio Manager at BB Biotech since 2014. Dr. Koch previously worked as a sell-side Pharma & Biotech Equity Analyst at Bank am Bellevue and Research Associate at the Institute of Pharmaceutical Sciences, ETH Zurich. He holds a PhD in Chemoinformatics & Computational Drug Design from ETH Zurich and a Masters in Bioinformatics from Goethe University Frankfurt.

Part of the Mark Allen Group.